title: Multicenter randomized trial comparing Zoladex with Zoladex plus flutamide in the treatment of advanced prostate cancer. Survival update. International Prostate Cancer Study Group.
authors.affiliation: CRC Research Unit, Plymouth General Hospital, Devon, United Kingdom.
authors.forename: C J
authors.initials: CJ
authors.lastname: Tyrrell
authors.forename: J E
authors.initials: JE
authors.lastname: Altwein
authors.forename: F
authors.initials: F
authors.lastname: Klippel
authors.forename: E
authors.initials: E
authors.lastname: Varenhorst
authors.forename: G
authors.initials: G
authors.lastname: Lunglmayr
authors.forename: F
authors.initials: F
authors.lastname: Boccardo
authors.forename: I M
authors.initials: IM
authors.lastname: Holdaway
authors.forename: J M
authors.initials: JM
authors.lastname: Haefliger
authors.forename: J P
authors.initials: JP
authors.lastname: Jordaan
authors.forename: M
authors.initials: M
authors.lastname: Sotarauta
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005485:Flutamide / Q000008:administration & dosage; D017273:Goserelin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate
chemical_list: D017273:Goserelin; D005485:Flutamide